TESSARI ed altri: Norme per la brevettabilità dei medicamenti

This procedure concerns the rules for patentability of medicines. It aims to clarify the conditions under which pharmaceutical products can be patented, ensuring a balance between innovation incentives and public access to medicines. The procedure affects pharmaceutical companies, researchers, and potentially patients by influencing the availability and cost of new drugs. It ensures compliance with existing intellectual property standards.